Table 2.
Patients for whom CXCL10 levels were measured in serum specimens that had been obtained at monthly intervals before, during, and after T1R
| Patient no. | Sex | Age range (yr) | Leprosy type | Reaction | Severity of reaction |
|---|---|---|---|---|---|
| 1 | F | 55 | BT | T1R | Moderate |
| 2 | M | 30 | BT | T1R | Moderate |
| 3 | M | 50 | BT | T1R | Moderate |
| 4 | M | 18 | BT | T1R | Severe |
| 5 | M | 32 | BT | T1R | Severe |
| 6 | F | 25 | BT | T1R | Severe |
| 7 | M | 38 | BT | T1R | Severe |
| 8 | M | 22 | BT | T1R | Moderate |
| 9 | M | 22 | BT | T1R | NDa |
| 10 | F | 33 | BT | T1R | Moderate |
| 11 | M | 45 | BL | T1R | Severe |
| 12 | M | 18 | BL | T1R | Severe |
| 13 | F | 35 | BL | T1R | Severe, moderateb |
| 14 | M | 50 | BL | T1R | Severe |
| 15 | F | 24 | BL | T1R | Moderate |
| 16 | M | 55 | BL | T1R | Severe |
| 17 | F | 48 | BL | T1R | Moderate |
| 18 | M | 36 | BL | T1R | ND |
| 19 | F | 15 | BL | T1R | ND |
| 20 | M | 30 | BL | T1R | ND |
ND, not done.
Patient had 2 reactions.